Abstract
Streptococcus pneumoniae was first identified as an infectious agent in the late nineteenth century. Subsequently, pneumococci have been established as the cause of a wide spectrum of diseases including pneumonia, otitis media, sinusitis, bacteremia and meningitis, as well as more unusual clinical complications such as pericarditis, endocarditis, arthritis and peritonitis.1,2 S. pneumoniae is a leading cause of community-acquired pneumonia in adults and meningitis in pediatric populations.3,4,5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.A. Mufson. Streptococcus pneumoniae. in “Principles and practices in infectious diseases” Mandell, G.L., Douglas, R.G., and Bennett, J.E. eds. Churchill Livingstone Inc., NY, NY (1991).
D.M. Musher. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clin Infect Dis. 14: 801–807 (1992).
T.J. Marrie. Community-acquired pneumonia. Clin Infect Dis. 18: 501–515 (1994).
B.M. Gray and H.C. Dillon. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis. 5: 201–207 (1986).
J. Ward. Antibiotic-resistant Streptococcus pneumoniae; clinical and epidemiologic aspects. Rev Infect Dis. 3: 254–66. 1981.
P.C. Appelbaum. World-wide development of antibiotic resistance in pneumococci. Eur J Clin Microbiol. 6: 367–367 (1987).
D. Hansman, L. Devitt, H. Miles, and I. Riley. Pneumococci relatively insensitive to penicillin from Australia and New Guinea. Med J Aust. 2: 353–356 (1974).
I. Niragi, G.P. Kirkpatrick, and S. Kabins. Relapsing pneumococcal meningitis: isolation of an organism with decreasing susceptibility to penicillin G. J Pediatr. 85: 671–673 (1974).
P.C. Appelbaum, A. Bhamjee, J.N. Scragg, A.F., Hallett, A.J. Bowen, and R.C. Cooper. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet. 2: 995–997 (1977).
M.R. Jacobs, H.J. Koornhof, R.M. Robins-Browne et al. Emergence of multiply resistant pneumococci. N Engl J Med. 299: 735–40. (1978).
F. Baquero, J. Martinez-Beltran, and E. Loza. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemotherap. 28 (Suppl. C): 31–38 (1991).
G.E. Schultze, S.L. Kaplan, and R.F. Jacobs. Resistant pneumococcus: a worldwide problem. Infection. 22: 233–237. (1994).
P.C. Appelbaum. Antimicrobial resistance in Streptococcus pneumoniae: An Overview. Clin Infect Dis. 15: 77–83. (1992).
A. Marton. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis. 15: 106–111. (1992).
K.P. Klugman and H.J. Koornhof. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 19791986. J Infect Dis. 158: 956–64. (1988).
H.J. Koornhof, A. Wasas, and K. Klugman. Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clin Infect Dis. 15: 8494 (1992).
J.R. Linares, R. Pallares, T. Alonso. J.L. Perez, J. Ayats, F. Gudiol, P.F. Viladrich, and R. Martin. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979–1990). Clin Inf Dis. 15: 99–105. (1992).
J. Linares, C. Latorre, C. Ardanuy, C. Munoz, F. Tubau, R. Martin. Program abstr 34th Intersci. Conf Antimicrob Agents Chemother, abstr. no. E6. page 48 (1994).
P.A. Geslin, A. Buu-Hoi, A. Fremaus, and J.F. Acar. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970–1990. Clin Infect Dis. 15: 95–8 (1992).
G. Lenoir, P. Gehanno, I. Boucot, and P. Berche. Program Abstr. 34th Intersci. Conf Antimicrob Agents Chemother, abstr. no. J 62. page 70 (1994).
R.R. Reinert, A. Queck, A. Karfhold, M. Kresken, and R. Lutticken. Antibiotic Sensitivity of Streptococcus pneumoniae isolated from normally sterile body sites: first results of a multicenter study in Germany. Infection. 22: 113 (1994).
R.N. Jones, E.N. Kehrberg, M.E. Erwin, S.C. Anderson, and the fluoroquinolone research surveillance group. Prevalence of important pathogens and resistance. Diag Microbiol Infect Dis. 19: 203–215 (1994).
R.F. Breimer, J.C. Butler, F.C. Tenover, J.A. Elliott, and R.R. Facklam. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 271: 1831–1835. (1994).
C. Thornsberry, J.M. Swenson, and R.R. Facklam. Antimicrobial resistance in pneumococci from the U.S.A. Are there trends?. Antimicrob Newsletter. 5: 2223. (1988).
J.O. Hendley, M.A. Sande, Stewart P.M. et al. Spread of Streptococcus pneumoniae in families. 1. Carriage rates and distribution of types. J Infect Dis. 132: 55–61. (1975).
J.M. Gwaltney, M. Sande, R. Austrian, R. et al. Spread of Streptococcus pneumoniae in families. II. Relation of transfer of Streptococcus pneumoniae to incidence of colds and serum antibody. J Infect Dis. 132: 62–8. (1975).
B.M. Gray, G.M. Converse, and H.C. Dillon. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis. 142: 923–93. 1980.
F.W. Henderson, P. H. Gilligan, K. Wait, and D. A. Goff. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis. 157: 256–263. (1988).
J. Ward. Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects. Rev Infect Dis. 3: 254–66. (1981).
A.M. Rauch, M. O’Ryan, R. Van, and L.K. Pickering. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Texas, day-care center. Amer J Dis Child. 144: 923–927. (1990).
J.M. Nava, F. Bella, J. Garau, J. Lite, M. Morera, C. Marti, D. Fontanals, B. Font, F. Pineda, S. Uriz, F. Deulofeu, A. Caleron, P. Duran, M. Grau, and A. Agudo. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: A population-based study. Clin Infect Dis. 19: 884–90, (1994).
R. Pallares, F. Gudiol, J. Linares, J. Ariza, G. Rufi, L. Murgui, J. L. Dorca, and P. F. Viladrich. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 317: 18–22. (1987).
M.E. Garcia-Leoni, E. Cercenado, P. Rodeno, J.C.L. Bernaldo de Quiros, D. Martinez-Hernanday, and E. Bouza. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis. 14: 427–435 (1992).
Streptococcus pneumoniae in “Zinsser Microbiology” 20th ed. Joklik W. K. et al. eds. Appleton and Lange, East Norwalk, Connecticut. (1992).
R.R. Facklam and J.A. Washington. Streptococcus and related catalase-negative gram-positive cocci in “Manual of Clinical Microbiology”, A. Balows et al. ed American Society of Microbiology, Washington, D.C. (1991).
J.C. Paton. Pathogenesis of pneumococcal disease. Cur Opin Infect Dis. 6: 363–368, (1993).
Clinical Microbiology Procedures Manual. Identification of catalase-negative aerobic gram-positive cocci. American Society of Microbiology, Washington, D.C. (1992).
R.N. Jones and D.C. Edson. special topics in antimicrobial susceptibility testing: test accuracy against methicillin-resistant Staphylococcus aureus, pneumococci, and the sensitivity of (3-lactamase methods. Am J Clin Pathol. 4 (Suppl.): 609–614 (1983).
National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests. Standard M2–A5. National Committee for Clinical Laboratory Standards, Villanova, Pa. (1993).
J.H. Jorgensen et al. Program Abstr. 33rd. Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 262, p. 167, 1993.
J.H. Jorgensen. Detection of antimicrobial resistance in Streptococcus pneumoniae by use of standardized susceptibility testing methods and recently developed interpretive criteria. Clin Microbiol Newsletter. 16: 97–101. (1994).
NCCLS broth dilution National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7–A3. National Committee for Clinical Laboratory Standards, Villanova, Pa. (1993).
M.R. Jacobs, H.J. Koornhof, R.M. Robins-Browne, C.M. Stevenson, Z.A. Vermacek, I. Freiman, G.B. Miller, M.A. Witcomb. M. Isaacson, J. I. Ward and R. Austrian. Emergence of multiply resistant pneumococci. N Engl J Med. 299: 735–740 (1978).
K. Carroll, S. Cohen, B. Saxon, and L. Hamilton. Failure of Micro Media FOX microdilution system to detect decreased susceptibility of Streptococcus pneumoniae to penicillin. J Clin Microbiol. 29: 2651–2652 (1991).
I.R. Friedland, S. Shelton, M. Paris, S. Rinderknecht, S. Ehrett, K. Krisher, and G. H. McCracken, Jr. Dilemmas in diagnosis and management of cephalosporin- resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 12: 196–200.
M.R. Jacobs. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis. 15: 119–127 (1992).
J.H. Jorgensen, A. W. Howell, and L.A. Maher. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test. J Clin Microbiol. 29: 109–114 (1990).
M.R. Jacobs, S. Bajaksouzian, P.C. Appelbaum, and A. Bolstrom. Evaluation of the E-test for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis. 15: 473–478 (1992).
R.B. Clark, O. Giger, and J.E. Mortensen. Comparison of susceptibility testing methods to detect penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis. 17: 213–217 (1993).
E. Macias, E.A., E. O. Mason, H. Y. Ocera, and M.R. LaRocco. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol. 32: 430–432 (1994).
J.H. Ngui-Yen, E. A. Bryce, C. Porter, and J.A. Smith. Evaluation of the E test by using selected gram-positive bacteria. J Clin Microbiol. 30: 2150–2152 (1992).
J.H. Jorgensen, M. J. Ferraro, M. L. McElmeel, J. Spargo, J. M. Swenson, and F.C. Tenover. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol. 32: 159–163 (1994).
K. Krisher and A. Linscott. Comparison of three commercial MIC systems, E test, Fastidious Antimicrobial Susceptibility Panel, and FOX Fastidious Panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae. 32: 2242–2245 (1994).
National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Informational Supplement. M100–S5. National Committee for Clinical Laboratory Standards, Villanova, Pa. (1994).
D.J. Waxman and J.L. Strominger. Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. Annu. Rev. Biochem. 52: 825–869. 1983.
R. Hakenbeck, S. Tomette, and N.F. Adkinson, Interaction of non-lytic betalactams with penicillin-binding proteins in Streptococcus pneumoniae. J Gen Microbiol. 133: 755–760 (1987).
E. Tuomanen and A. Tomasz. Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics. Scand J Infect Dis (Suppl). 74: 102–112 (1991).
T.D. McDowell and K.E., Reed. Mechanism of penicillin killing in the absence of bacterial lysis. Antimicrob Agents Chemotherap. 33: 1680–1685 (1989).
A. Markiewicz and A. Tomasz. Variation in penicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci. J Clin Microbiol. 27: 405–410 (1989).
S. Handwerger and A. Tomasz. Alterations in kinetic properties of penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemotherap. 30: 57–63 (1986).
C.G. Dowson, A. Hutchison, N. Woodford, A.P. Johnson, R.C. George, and B.G. Spratt. Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc. Natl. Acad. Sci USA 87: 5858–5862 (1990).
R. Munoz, J.M. Musser, M. Crain, D.E. Briles, A. Marton, A.J. Parkinson, U. Sorensen, and A. Tomasz. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis. 15: 112–118 (1992).
R. Hakenbeck, L. Briese, Chalkley, H. Ellerbrok, R. Kalliokoski, C. Latorre, M. Leinonen, and C. Martin. Antigenic variation of penicillin-binding proteins from penicillin-resistant clinical strains of Streptococcus pneumonĂae. J Infect Dis. 164: 313–319 (1991).
G. Laible, B.G. Spratt, and R. Hakenbeck. Interspecies recombinations events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol Micro. 5: 1993–2002 (1991).
A.M. Smith, K. P. Kingman, T.J. Coffey, and B.G. Spratt. Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South Africa. Antimicrob Agents Chemotherap. 37: 1938–1944.
R. Munoz, T. Coffey, M. Daniels, C.G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J.M. Musser, B.G. Spratt, and A. Tomasz. Intercontinental spread of a multiresistant clone of serotype 23f Streptococcus pneumoniae. J. Infect. Dis. 164: 302–306 (1991).
L.K. McDougal, R. Facklam, M. Reeves, S. Hunter, J.M. Swenson, B.C. Hill, and F.C. Tenover. Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob. Agents Chemotherap. 36: 2176–2184 (1992).
R. Munoz., C.G. Dowson, M. Daniles, T.M. Coffey, C. Martin, R. Ilakenbeck, and B.G. Spratt. Genetics of resistance to third-generation ccphalosporins in clinical isolates of Streptococcus pneumoniae. Mol Micro. 6: 2461–2465 (1992).
P. Moreillon, A. Markiewicz, S. Nachman, and A. Tomasz. Two bactericidal targets for penicillin in pneumococci: autolysis-dependent and autolysis-independent killing mechanisms. Antimicrob. Agents Chemotherap. 34: 33–39 (1990).
H.H. Lui and A. Tomasz. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J Infect Dis. 152: 365–372 (1985).
M.G. Tauber and M.A. Sande. Pharmacodynamies of antibiotics in experimental bacterial meningitis: two sides to rapid bacterial killing in cerebrospinal fluid. Scand J Infect Dis (Suppl). 74: 173–178 (1990).
K.P. Klugman. Pneumococcal resistance to antibiotics. Clin Micrbiol Rev. 3: 171–196 (1990).
G.A. Jacoby and G.L. Archer. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med. 324: 601–12 (1991).
P.F. Viladrich, F. Gudiol, J. Linares, G. Rufi, J. Ariza, and R. Pallares. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med. 84: 839–46 (1988).
M.M. Sloas, F.F. Barrett, P.J. Chesney, et al. Cephalosporin treatment failure in penicillin and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 11: 662–6 (1992).
J.S. Bradley and J.D. Connor. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J. 10: 871–3 (1991).
I.R. Friedland, S. Shelton, M. Paris, et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 12: 196–200 (1993).
M.J. Catalan, J.M. Fernandez, A.Vazquez, E. Varela da Seijas, A. Suarez, and J.C.Bernaldo de Quiros. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis. 18: 766769. 1993.
C.C. John. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis. 18: 188–193 (1994).
I.R. Friedland and G.H. McCracken. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 331: 377–382, (1994).
I.R. Friedland and G.R. Istre. Management of penicillin-resistant pneumococcal infections. Pediatr Infect Dis. 11: 433–5 (1992).
I.R. Friedland, M. Paris, S. Shelton, and G.H. McCracken. Time-kill studies of antibiotic combinations against penicillin-resistant and susceptible Streptococcus pneumoniae. J Antimicrob Chemotherap. 34: 213–237 (1994).
P.F. Viladrich, F. Gudiol, F. Linares, R. Pallares, I. Sabate, G. Rufi, and J. Ariza. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemotherap. 35: 2467–2472 (1991).
P.F. Viladrich, F. Gudiol, J. Linares, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemotherap. 35: 2467–72 (1991).
P.F. Viladrich, F. Gudiol, J. Linares, G. Rufi, J. Ariza, and R. Pallares. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med. 84: 839–46 (1988).
I.R. Friedland and K.P. Klugman. Recurrent penicillin-resistant pneumococcal meningitis after chloramphenicol therapy. Pediatr Infect Dis J. 10: 705–707 (1991).
I.R. Friedland and K.P. Klugman. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet. 339: 405–8 (1992).
Y. Sakata, G.H. McCracken Jr., M.L Thomas, and K.D. Olsen. Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin-and chloramphenicol-resistant strain of Haemophilus influenzae type b. Antimicrob Agents Chemotherap. 25: 29–32 (1984).
J.O. Klein, R.D. Feigin, and G.H. McCracken, Jr. Report of the task force on diagnosis and management of meningitis. Pediatrics. 78: 959–982 (1986).
F. Asensi, D. Perez-Tamarit, M.C. Otero, et al. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus [letter]. Pediatr Infect Dis J. 8: 895 (1989).
V.K. Wong, H.T. Wright Jr., L.A. Ross, W.H. Mason, C.B. Inderlied, and K.S. Kim. Imipenem-cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J. 10: 122–5 (1991).
J.I. Ward and R.C. Moellering Jr. Susceptibility of pneumococci to 14 beta-lactam agents; comparison of strains resistant, intermediate-resistant, and susceptible to penicillin. Antimicrob Agents Chemotherap. 20: 204–7 (1981).
D.J. Tweardy, M.R. Jacobs, and W.T. Speck. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis. J Antimicrob Chemotherap. 12: 133–9 (1983).
G.A. Pankuch, M.R. Jacobs, and P.C. Appelbaum. Susceptibilities of 200 penicillin-susceptible and resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, cetrazidime and ceftriaxone. Antimicrobial Agents Chemotherap. 38: 2905–2907 (1994).
J.R. Lonks and A.A. Medeiros. High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. Antimicrob Agents Chemotherap. 37: 1742–1745 (1993).
Spangler, S.K. M. R. Jacobs, and P.C. Appelbaum. Susceptibilities of penicillin-susceptible and resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, Sparfloxacin, Tematloxacin, Win 57273, Ofloxacin, and Ciprofloxacin. Antimicrob Agents Chemotherap. 36: 856–859.
S.K. Spangler, M.R. Jacobs, and P.C. Appelbaum. In vitro susceptibilities of 185 penicillin-susceptible and resistant pneumococci to WY-49605, a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrob Agents Chemotherap. 38:2902–2904. (1994).
P. Gehanno, G. Lenoir, and P. Berche. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemotherap. 39:271–272. (1995).
M.M. Paris, S. Shelton, D. Krisher, and G.H. McCracken. Otitis media (OM) caused by penicillin and cephalosporin resistant Streptococcus preumoniae (P+CRSp). Pediatric Research. 35: 191A. (1994).
A.L. Barry, M.A. Pfaller, P. C. Fuchs, and R.R. Packer. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992–1993. Antimicrob Agents Chemotherap. 38:2419–2425. (1994).
B. Barry, M. Muffat-Joly, P. Gehanno, and J.J. Pocidalo. Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemotherap. 37: 1599–1603.
P.J. Krause, N.J. Owens, C.H. Nightingale, J. J. Klimek., W.B. Lehnamm, and R. Quintilliani. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis. 145: 815–821 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Krisher, K. (1995). Antibiotic-Resistance in Streptococcus Pneumoniae . In: Jungkind, D.L., Mortensen, J.E., Fraimow, H.S., Calandra, G.B. (eds) Antimicrobial Resistance. Advances in Experimental Medicine and Biology, vol 390. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9203-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9203-4_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9205-8
Online ISBN: 978-1-4757-9203-4
eBook Packages: Springer Book Archive